Novartis

Fabrikstrasse 2, 4056 Basel
Novartis   link
Ort: Basel
Kategorie: Pharmakologie
Verbunden:

Research & Development at Novartis The Novartis Pharmaceuticals clinical pipeline holds a broad stream of 140 future projects including both new molecular entities and additional indications or formulations for marketed products. Our pipeline has consistently being ranked by experts as one of the strongest in the industry. Our scientists focus on diseases for which medical need remains unmet and strive to improve the drug discovery process with an approach that integrates novel concepts and tools across multiple disease areas.

#display_name

Pharmakologie - Gesundheit - 6.12
Patients & Caregivers Healthcare Professionals Society & ESG Once-daily QMF149 met primary endpoint of lung function improvement and key secondary endpoint of asthma control improvement versus mometasone furoate 1 -   QMF149 showed improvement in peak expiratory flow, exacerbation rates, rescue medication use versus mometasone furoate am
Pharmakologie - Gesundheit - 5.12

Patients & Caregivers Healthcare Professionals Society & ESG - Uniquely positioned with global scale, focus on innovative medicines, diversification across therapeutic areas and exposure to cutting-edge platforms 60 projects in Phase 2 pipeline with 10+ advancing into Phase 3 or pivotal tri

Pharmakologie - Gesundheit - 2.12

Patients & Caregivers Healthcare Professionals Society & ESG With more than 140 abstracts, Novartis continues its leadership in hematology innovation -   Data for MBG453, an innovative anti-TIM-3 immunotherapy, with decitabine on preliminary response rates in patients with high-risk MDS a

Pharmakologie - 21.11

Patients & Caregivers Healthcare Professionals Society & ESG - o   The Novartis Innovation Prize: Assistive Tech for Multiple Sclerosis (MS) identifies and embraces technology that aims to improve mobility and daily life for people living with MS o   Applications are open worldwide to the t

Pharmakologie - Gesundheit - 15.11

Patients & Caregivers Healthcare Professionals Society & ESG Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications 1 -   Adakveo reduced the annual rate of sickle cell pain crises by 45% compared to placebo (1.63 vs 2.98) and

Gesundheit - 5.12

Patients & Caregivers Healthcare Professionals Society & ESG - Basel, December 5, 2019 - Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Medusa Merger Corporation, a Delaware corporation ("Purchaser"), has commenced a cash tender offer to pu

Pharmakologie - Gesundheit - 24.11

Patients & Caregivers Healthcare Professionals Society & ESG Over 50 million secondary prevention patients worldwide with atherosclerotic cardiovascular disease (ASCVD) or familial hypercholesterolemia (FH) on current standard of care do not achieve LDL cholesterol (LDL-C) goal and remain

Pharmakologie - Gesundheit - 17.11

Patients & Caregivers Healthcare Professionals Society & ESG - Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compared to valsartan 1 -   Entresto, compared to valsartan, demonstrated reduced risk in total heart fai

Pharmakologie - Gesundheit - 15.11

Patients & Caregivers Healthcare Professionals Society & ESG - If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients with active secondary progressive multiple sclerosis (SPMS) in Europe ) -   CHMP opinion is based on the Phase III EX



Stellenangebote

» Stellenangebote: Novartis

Letzten Stellenangebote



website preview

Link

Medizin und Biowissenschaften